Delivery Order 75D30123D18241-75D30123F00001
- Duke University's Office of Research Administration received a delivery order contract valued at $1.07M under the Clinical Immunization Safety Assessment (CISA) master IDIQ vehicle from the CDC Pittsburgh on September 29, 2017. This cost-no-fee contract, which extended through September 28, 2022, supported COVID response efforts and was performed at Duke's Durham, North Carolina location. The award was made on a competitive basis with no set-aside designation. The Clinical Immunization Safety...
- Duke University's Office of Research Administration was awarded a delivery order contract by the CDC Office of Acquisition Services (through its parent Clinical Immunization Safety Assessment (CISA) vehicle) valued at $20,767 on September 29, 2014, with completion targeted for September 28, 2015. The contract was awarded on a cost, no-fee basis without set-aside designation, reflecting a competitive selection based on Duke's technical qualifications. Work was performed at Duke's Durham, North...
- The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...
- Duke University Office of Research Administration Division was awarded a $499,784 firm fixed price delivery order against its Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract with the Centers for Disease Control and Prevention (CDC). The delivery order is for a CISA SHINGRIX lead study to be performed in Durham, North Carolina by November 2022. Duke University holds the CISA IDIQ contract with CDC, valued at up to $86 million through...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $608,717 delivery order contract to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The contract has a period of performance ending on September 30, 2020 and is not associated with a set-aside. This delivery order is part of a larger CISA indefinite delivery, indefinite quantity (IDIQ) contract with a...
- This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Duke University's Office of Research Administration Division. The $263,144.00 award is a delivery order under the CDC's Clinical Immunization Safety Assessment (CISA) master indefinite-delivery, indefinite-quantity (IDIQ) contract, which has a potential value of $86 million through September 2028. Under this contract, Duke University provides clinical research...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University to provide clinical research and immunization safety assessment services under the indefinite delivery indefinite quantity (IDIQ) Clinical Immunization Safety Assessment (CISA) contract vehicle. The award has a ceiling value of $549,433.00 and the period of performance runs through September 29, 2020. The contract does not have a set-aside designation. As a prime contractor for the...
- This federal contract was awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Duke University to provide Clinical Immunization Safety Assessment (CISA) services. The contract is a Delivery Order under the CISA master IDIQ contract, which has a potential value of $86 million through September 2028. Two task orders have been awarded to date - one valued at $875,045 for CISA services in Durham, NC from September 2023 to...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University. The contract was awarded under the Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) vehicle. The contract has a ceiling value of $713,975.00 and was awarded on September 29, 2016, with an ultimate completion date of October 28, 2019. The contract is for the delivery of clinical research and immunization safety assessment services. The...
- This is a delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Duke University Office Of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The order, valued at $243,907.39, is under a larger CISA IDIQ contract that has a potential value of $86 million through September 2028. As the prime contractor, Duke University will perform the work in Durham, North Carolina. No set-aside...
- 75D30123D18241Indefinite Delivery Contract
- 75D30123D18241-75D30123F00001Delivery Order
Duke University's Office of Research Administration was awarded a delivery order under the 2023 Clinical Immunization Safety Assessment (CISA) Base IDIQ contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh on September 28, 2023. This cost-plus-no-fee contract, valued at $874,846, supports immunization safety assessment services and will be performed in Durham, North Carolina, with an ultimate completion date of September 27, 2028. The award was made through a competitive process with no set-aside designation, leveraging Duke University's established capabilities in clinical research and vaccine-related programs. This delivery order represents Duke University's continued engagement in vaccine evaluation and immunization research for federal agencies. Given Duke's significant existing role managing large-scale vaccine testing programs, including a $136.6 million IDV with the National Institute of Allergy and Infectious Diseases focused on evaluation and testing services for vaccines and biologics, this CISA contract aligns with the university's core competencies in clinical trial infrastructure, regulatory science, and pediatric drug development. The work supports the CDC's critical mission of ensuring immunization safety for the U.S. population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $163.9k | 9/24/25 | |
| P00002 | Exercise an Option | $163.4k | 8/27/24 | |
| P00001 | Supplemental Agreement for work within scope | $3.5k | 8/9/24 | |
| Not listed | Not listed | $198.8k | 9/26/23 |